In the News
In the News
Elizabeth Nesoff, PhD, MPH discusses her recently published study in the Leonard Davis Institute of Health Economics (LDI) blog investigating neighborhood features that were correlated with fatal opioid overdoses among the homeless population in New York City. Dr. Nesoff uses these discoveries to make important policy recommendations with respect to targeted outreach and other interventions.
Jeffrey Morris, PhD and Jeffrey Gerber, MD, PhD, MSCE collaborated with researchers to examine measles serostatus among pregnant persons about to give birth and whether rubella serostatus, which is routinely assessed during pregnancy, can serve as a proxy for measles serostatus.
Anne Marie McCarthy, PhD was featured on the Real Pink Podcast where she discussed the development of new ways to identify people with high risk of aggressive breast cancer.
Penn Medicine has opened a Center for Living Donation, bringing under one roof its services for patients who receive kidney, liver, and uterus transplants with organs donated by living people. Therese Bittermann, MD, MSCE the medical director of Penn’s living donor program for liver transplant comments on this new center.
Dr. Kevin Johnson, MD, MS, FAAP, FAMIA, FACMI shares his experience trying to donate blood as a gay man and discusses how the Unites States has more restrictive rules than the United Kingdom, Mexico, and Canada when it comes to allowing gay men to donate blood.
Stroke, Clot Risk Halved in Patients with Heart Disease and Arrhythmia Who Took Blood Thinners Apixaban Versus Rivaroxaban
A difference in the effectiveness against strokes and other blood clots was easily visible in the first year among patients who’d taken the anticoagulant apixaban rather than rival rivaroxaban, according to Sean Hennessy, PharmD, PhD, Professor of Epidemiology and Director of Penn’s Center for Real-world Effectiveness and Safety of Therapeutics,and Ghadeer Dawwas, PhD, a postdoctoral fellow in the DBEI.
Penn Medicine researchers will help lead the development of an algorithm to flag patients at risk of rare disease thanks to a $4.7 million NIH grant. This 4-year U01 will involve 10 national health systems (with a total of 27 million patients) for developing federated learning and transfer learning algorithms using real-world data for early detection of rare diseases.
The efforts to develop this prediction method, called “PANDA: Predictive Analytics via Networked Distributed Algorithms for multi-system diseases,” will be led by principal investigators from the DBEI Drs. Yong Chen, Professor of Biostatistics, and Peter A. Merkel, Chief of Rheumatology and a Professor of Medicine and Epidemiology, as well as Jiang Bian, Chief Data Scientist of the University of Florida Health System and a Professor in the Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
First study author, Joel M. Gelfand, MD, MSCE, and the investigators discovered that apremilast (brand name Otezla), which has helped psoriasis patients achieve clearer skin and ease the symptoms of their psoriatic arthritis, could also help people with psoriasis shed unhealthy body fat and therefore improve cardiovascular health, a well-known vulnerability for those with psoriasis.
Read the article in JAMA Dermatology.
Joe Biden says the pandemic is over. Experts said the definition of a pandemic depends on how society reacts. But is it?
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics.